Metal ion acquisition in Staphylococcus aureus: Overcoming nutritional immunity

Seminars in Immunopathology

Volumn 34, Issue 2, 2012, Pages 215-235

  Cassat, James E ^a   Skaar, Eric P ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calprotectin; Copper; Iron; Manganese; Staphylococcus aureus; Zinc

Indexed keywords

CALGRANULIN; CALGRANULIN A; CALGRANULIN B; COPPER; HEMOPROTEIN; MANGANESE; METAL ION; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; SIDEROPHORE; STAPHYLOFERRIN A; STAPHYLOFERRIN B; TRANSFERRIN; UNCLASSIFIED DRUG; ZINC;

BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BINDING AFFINITY; GENE EXPRESSION REGULATION; GENE MUTATION; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; MASS SPECTROMETRY; METAL METABOLISM; NONHUMAN; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; COPPER; HOST-PATHOGEN INTERACTIONS; HUMANS; IONS; MANGANESE; MASS SPECTROMETRY; METALS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; ZINC;

EID: 84859826167     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-011-0294-4     Document Type: Review

References (231)

1. Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, Spalding J, Jiang J, Oster G (2009) Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 15(9):1516-1518
2. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355(7):666-674. doi:10.1056/NEJMoa055356
3. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111(23):e394-e434. doi:10.1161/CIRCULATIONAHA.105.165564
4. Lew DP, Waldvogel FA (2004) Osteomyelitis. Lancet 364 (9431):369-379. doi:10.1016/S0140-6736(04)16727-5
5. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Patel PR, Fridkin SK (2010) Health care-associated invasive MRSA infections, 2005-2008. Jama 304(6):641-648. doi:10.1001/jama.2010.1115
6. Kirby WM (1944) Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science 99(2579):452-453. doi:10.1126/science.99.2579.452
7. Barber M (1961) Methicillin-resistant staphylococci. J Clin Pathol 14:385-393
8. Nannini E, Murray BE, Arias CA (2010) Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 10(5):516-521. doi:10.1016/j.coph.2010.06.006
9. Schaffer AC, Lee JC (2009) Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am 23(1):153-171. doi:10.1016/j.idc.2008.10.005
10. David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23(3):616-687. doi:10.1128/CMR.00081-09
11. Bartlett AH, Hulten KG (2010) Staphylococcus aureus pathogenesis: secretion systems, adhesins, and invasins. Pediatr Infect Dis J 29(9):860-861. doi:10.1097/INF.0b013e3181ef2477
12. Gordon RJ, Lowy FD (2008) Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46(Suppl 5):S350-S359. doi:10.1086/533591 (Pubitemid 351717322)
13. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199(5):687-695. doi:10.1084/jem.20031636 (Pubitemid 38316435)
14. Dumont AL, Nygaard TK, Watkins RL, Smith A, Kozhaya L, Kreiswirth BN, Shopsin B, Unutmaz D, Voyich JM, Torres VJ (2011) Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol 79(3):814-825. doi:10.1111/j.1365-2958.2010.07490.x
15. Menestrina G, Serra MD, Prevost G (2001) Mode of action of beta-barrel pore-forming toxins of the staphylococcal alpha-hemolysin family. Toxicon 39(11):1661-1672 (Pubitemid 32786998)
16. Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT (2002) Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med 8(7):687-693. doi:10.1038/nm728 (Pubitemid 34778721)
17. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13(12):1510-1514. doi:10.1038/nm1656 (Pubitemid 350224240)
18. Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ (2007) Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 109(7):2936-2943. doi:10.1182/blood-2006-06-015461 (Pubitemid 46482091)
19. Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6(9):920-927. doi:10.1038/ni1235 (Pubitemid 43090447)
20. Lee LY, Hook M, Haviland D, Wetsel RA, Yonter EO, Syribeys P, Vernachio J, Brown EL (2004) Inhibition of complement activation by a secreted Staphylococcus aureus protein. J Infect Dis 190(3):571-579. doi:10.1086/422259 (Pubitemid 38982098)
21. Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF (2008) The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog 4(12):e1000250. doi:10.1371/journal.ppat.1000250
22. Langley R, Wines B, Willoughby N, Basu I, Proft T, Fraser JD (2005) The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol 174(5):2926-2933 (Pubitemid 40279711)
23. Forsgren A, Nordstrom K (1974) Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG. Ann N Y Acad Sci 236:252-266
24. Thakker M, Park JS, Carey V, Lee JC (1998) Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect Immun 66(11):5183-5189 (Pubitemid 29044607)
25. Nilsson IM, Lee JC, Bremell T, Ryden C, Tarkowski A (1997) The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun 65(10):4216-4221 (Pubitemid 27422080)
26. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 193(9):1067-1076 (Pubitemid 32436200)
27. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274(13):8405-8410 (Pubitemid 29164628)
28. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M (2007) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66(5):1136-1147. doi:10.1111/j.1365-2958.2007.05986.x (Pubitemid 350115022)
29. Jonsson K, McDevitt D, McGavin MH, Patti JM, Hook M (1995) Staphylococcus aureus expresses a major histocompatibility complex class II analog. J Biol Chem 270(37):21457-21460
30. Lee LY, Miyamoto YJ, McIntyre BW, Hook M, McCrea KW, McDevitt D, Brown EL (2002) The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest 110(10):1461-1471. doi:10.1172/JCI16318 (Pubitemid 35396917)
31. Kochan I (1973) The role of iron in bacterial infections, with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol 60:1-30
32. Weinberg ED (2009) Iron availability and infection. Biochim Biophys Acta 1790(7):600-605. doi:10.1016/j.bbagen.2008.07.002
33. Braun V, Hantke K, Koster W (1998) Bacterial iron transport: mechanisms, genetics, and regulation. Met Ions Biol Syst 35:67-145
34. Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, Skaar EP (2008) Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319(5865):962-965. doi:10.1126/science.1152449 (Pubitemid 351263768)
35. Ganz T, Nemeth E (2006) Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta 1763(7):690-699. doi:10.1016/j.bbamcr.2006.03.014 (Pubitemid 44189542)
36. Le NT, Richardson DR (2002) The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603(1):31-46 (Pubitemid 35257983)
37. Lukianova OA, David SS (2005) A role for iron-sulfur clusters in DNA repair. Curr Opin Chem Biol 9(2):145-151. doi:10.1016/j.cbpa.2005.02.006 (Pubitemid 40467576)
38. Crichton R (2001) Inorganic biochemistry of iron metabolism: from molecular mechanisms to clinical consequences, vol 2. Wiley, West Sussex
39. Vadillo M, Corbella X, Pac V, Fernandez-Viladrich P, Pujol R (1994) Multiple liver abscesses due to Yersinia enterocolitica discloses primary hemochromatosis: three cases reports and review. Clin Infect Dis 18(6):938-941 (Pubitemid 24171340)
40. Barton JC, Acton RT (2009) Hemochromatosis and Vibrio vulnificus wound infections. J Clin Gastroenterol 43(9):890-893. doi:10.1097/MCG.0b013e31819069c1
41. Weinberg ED (2000) Microbial pathogens with impaired ability to acquire host iron. Biometals 13(1):85-89
42. Manso C, Rivas I, Peraire J, Vidal F, Richart C (1997) Fatal Listeria meningitis, endocarditis and pericarditis in a patient with haemochromatosis. Scand J Infect Dis 29(3):308-309
43. Posey JE, Gherardini FC (2000) Lack of a role for iron in the Lyme disease pathogen. Science 288(5471):1651-1653 (Pubitemid 30387432)
44. Archibald F (1986) Manganese: its acquisition by and function in the lactic acid bacteria. Crit Rev Microbiol 13(1):63-109. doi:10.3109/ 10408418609108735
45. Meiwes J, Fiedler HP, Haag H, Zahner H, Konetschny-Rapp S, Jung G (1990) Isolation and characterization of staphyloferrin A, a compound with siderophore activity from Staphylococcus hyicus DSM 20459. FEMS Microbiol Lett 55(1-2):201-205 (Pubitemid 20066071)
46. Courcol RJ, Trivier D, Bissinger MC, Martin GR, Brown MR (1997) Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun 65(5):1944-1948 (Pubitemid 27193624)
47. Beasley FC, Vines ED, Grigg JC, Zheng Q, Liu S, Lajoie GA, Murphy ME, Heinrichs DE (2009) Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol Microbiol 72(4):947-963. doi:10.1111/j.1365-2958.2009.06698.x
48. Friedman DB, Stauff DL, Pishchany G, Whitwell CW, Torres VJ, Skaar EP (2006) Staphylococcus aureus redirects central metabolism to increase iron availability. PLoS Pathog 2(8):e87. doi:10.1371/journal.ppat.0020087
49. Horsburgh MJ, Ingham E, Foster SJ (2001) In Staphylococcus aureus, Fur is an interactive regulator with PerR, contributes to virulence, and is necessary for oxidative stress resistance through positive regulation of catalase and iron homeostasis. J Bacteriol 183(2):468-475. doi:10.1128/JB.183.2.468-475.2001 (Pubitemid 32048104)
50. Hantke K (1981) Regulation of ferric iron transport in Escherichia coli K12: isolation of a constitutive mutant. Mol Gen Genet 182(2):288-292
51. Xiong A, Singh VK, Cabrera G, Jayaswal RK (2000) Molecular characterization of the ferric-uptake regulator, Fur, from Staphylococcus aureus. Microbiology 146(Pt 3):659-668 (Pubitemid 30157661)
52. Cotton JL, Tao J, Balibar CJ (2009) Identification and characterization of the Staphylococcus aureus gene cluster coding for staphyloferrin A. Biochemistry 48(5):1025-1035. doi:10.1021/bi801844c
53. Speziali CD, Dale SE, Henderson JA, Vines ED, Heinrichs DE (2006) Requirement of Staphylococcus aureus ATP-binding cassette-ATPase FhuC for iron-restricted growth and evidence that it functions with more than one iron transporter. J Bacteriol 188(6):2048-2055. doi:10.1128/JB.188.6.2048-2055.2006 (Pubitemid 43376458)
54. Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O (2004) Iron-source preference of Staphylococcus aureus infections. Science 305(5690):1626-1628. doi:10.1126/science.1099930 (Pubitemid 39296358)
55. Grigg JC, Cooper JD, Cheung J, Heinrichs DE, Murphy ME (2010) The Staphylococcus aureus siderophore receptor HtsA undergoes localized conformational changes to enclose staphyloferrin A in an arginine-rich binding pocket. J Biol Chem 285(15):11162-11171. doi:10.1074/jbc.M109.097865
56. Drechsel H, Freund S, Nicholson G, Haag H, Jung O, Zahner H, Jung G (1993) Purification and chemical characterization of staphyloferrin B, a hydrophilic siderophore from staphylococci. Biometals 6(3):185-192
57. Cheung J, Beasley FC, Liu S, Lajoie GA, Heinrichs DE (2009) Molecular characterization of staphyloferrin B biosynthesis in Staphylococcus aureus. Mol Microbiol 74(3):594-608. doi:10.1111/j.1365-2958.2009.06880.x
58. Dale SE, Sebulsky MT, Heinrichs DE (2004) Involvement of SirABC in iron-siderophore import in Staphylococcus aureus. JBacteriol 186(24):8356-8362. doi:10.1128/JB.186.24.8356-8362.2004 (Pubitemid 39603226)
59. Grigg JC, Cheung J, Heinrichs DE, Murphy ME (2010) Specificity of Staphyloferrin B recognition by the SirA receptor from Staphylococcus aureus. J Biol Chem 285(45):34579-34588. doi:10.1074/jbc.M110.172924
60. Beasley FC, Marolda CL, Cheung J, Buac S, Heinrichs DE (2011) Staphylococcus aureus transporters Hts, Sir, and Sst capture iron liberated from human transferrin by staphyloferrin a, staphyloferrin B, and catecholamine stress hormones, respectively, and contribute to virulence. Infect Immun 79(6):2345-2355. doi:10.1128/IAI.00117-11
61. Brock JH, Ng J (1983) The effect of desferrioxamine on the growth of Staphylococcus aureus, Yersinia enterocolitica and Streptococcus faecalis in human serum: uptake of desferrioxamine-bound iron. FEMS Microbiol Lett 20(3):439-442 (Pubitemid 14223800)
62. Sebulsky MT, Hohnstein D, Hunter MD, Heinrichs DE (2000) Identification and characterization of a membrane permease involved in iron-hydroxamate transport in Staphylococcus aureus. J Bacteriol 182(16):4394-4400 (Pubitemid 30599800)
63. Sebulsky MT, Heinrichs DE (2001) Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus. J Bacteriol 183(17):4994-5000 (Pubitemid 32750926)
64. Neupane GP, Kim DM (2009) Comparison of the effects of deferasirox, deferiprone, and deferoxamine on the growth and virulence of Vibrio vulnificus. Transfusion 49(8):1762-1769. doi:10.1111/j.1537-2995.2009.02186.x
65. Lesic B, Foulon J, Carniel E (2002) Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica. Antimicrob Agents Chemother 46(6):1741-1745 (Pubitemid 34535191)
66. Boelaert JR, de Locht M, Van Cutsem J, Kerrels V, Cantinieaux B, Verdonck A, Van Landuyt HW, Schneider YJ (1993) Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 91(5):1979-1986. doi:10.1172/JCI116419 (Pubitemid 23141469)
67. Morrissey JA, Cockayne A, Hill PJ, Williams P (2000) Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus. Infect Immun 68(11):6281-6288
68. Cendrowski S, MacArthur W, Hanna P (2004) Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence. Mol Microbiol 51(2):407-417. doi:10.1046/j.1365-2958.2003.03861.x (Pubitemid 38142130)
69. Cox CD (1982) Effect of pyochelin on the virulence of Pseudomonas aeruginosa. Infect Immun 36(1):17-23
70. Meyer JM, Neely A, Stintzi A, Georges C, Holder IA (1996) Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect Immun 64(2):518-523 (Pubitemid 26032823)
71. Heesemann J, Hantke K, Vocke T, Saken E, Rakin A, Stojiljkovic I, Berner R (1993) Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane polypeptide of 65,000 Da and pesticin sensitivity. Mol Microbiol 8(2):397-408
72. Allard KA, Dao J, Sanjeevaiah P, McCoy-Simandle K, Chatfield CH, Crumrine DS, Castignetti D, Cianciotto NP (2009) Purification of Legiobactin and importance of this siderophore in lung infection by Legionella pneumophila. Infect Immun 77(7):2887-2895. doi:10.1128/IAI.00087-09
73. Williams PH (1979) Novel iron uptake system specified by ColV plasmids: an important component in the virulence of invasive strains of Escherichia coli. Infect Immun 26(3):925-932
74. Dale SE, Doherty-Kirby A, Lajoie G, Heinrichs DE (2004) Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore. Infect Immun 72(1):29-37 (Pubitemid 38018157)
75. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10(5):1033-1043 (Pubitemid 36001971)
76. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432(7019):917-921. doi:10.1038/ nature03104 (Pubitemid 40037155)
77. Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW (2006) Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 103(6):1834-1839. doi:10.1073/pnas.0510847103 (Pubitemid 43228779)
78. Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Mak TW, Clifton MC, Strong RK, Ray P, Kolls JK (2009) Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 182(8):4947-4956. doi:10.4049/jimmunol.0803282
79. Johnson EE, Srikanth CV, Sandgren A, Harrington L, Trebicka E, Wang L, Borregaard N, Murray M, Cherayil BJ (2010) Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages. FEMS Immunol Med Microbiol 58(1):138-145. doi:10.1111/j.1574-695X.2009.00622.x
80. Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK (2005) Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 13(1):29-41. doi:10.1016/j.str.2004.10.009 (Pubitemid 40092472)
81. Nelson AL, Barasch JM, Bunte RM, Weiser JN (2005) Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol 7(10):1404-1417. doi:10.1111/j.1462-5822.2005.00566.x (Pubitemid 41335245)
82. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J (2005) Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115(3):610-621. doi:10.1172/JCI23056 (Pubitemid 40322235)
83. Wilson MK, Abergel RJ, Raymond KN, Arceneaux JE, Byers BR (2006) Siderophores of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Biochem Biophys Res Commun 348(1):320-325. doi:10.1016/j.bbrc.2006.07.055 (Pubitemid 44163512)
84. Abergel RJ, Wilson MK, Arceneaux JE, Hoette TM, Strong RK, Byers BR, Raymond KN (2006) Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A 103(49):18499-18503. doi:10.1073/pnas.0607055103 (Pubitemid 44913439)
85. Hantke K, Nicholson G, Rabsch W, Winkelmann G (2003) Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A 100(7):3677-3682. doi:10.1073/pnas.0737682100 (Pubitemid 36418091)
86. Young NS, Gerson SL, High KA (2006) Clinical hematology, vol 1. Mosby Elsevier, Philadelphia
87. Everse J, Hsia N (1997) The toxicities of native and modified hemoglobins. Free Radic Biol Med 22(6):1075-1099 (Pubitemid 27084145)
88. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409(6817):198-201. doi:10.1038/35051594 (Pubitemid 32144285)
89. Allhorn M, Berggard T, Nordberg J, Olsson ML, Akerstrom B (2002) Processing of the lipocalin alpha(1)-microglobulin byhemoglobin induces heme-binding and heme-degradation properties. Blood 99(6):1894-1901 (Pubitemid 34525466)
90. Anzaldi LL, Skaar EP (2010) Overcoming the heme paradox: heme toxicity and tolerance in bacterial pathogens. Infect Immun 78(12):4977-4989. doi:10.1128/IAI.00613-10
91. Tong Y, Guo M (2009) Bacterial heme-transport proteins and their heme-coordination modes. Arch Biochem Biophys 481(1):1-15. doi:10.1016/j.abb. 2008.10.013
92. Mazmanian SK, Liu G, Ton-That H, Schneewind O (1999) Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 285(5428):760-763
93. Mazmanian SK, Ton-That H, Schneewind O (2001) Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus. Mol Microbiol 40(5):1049-1057 (Pubitemid 32574974)
94. Mazmanian SK, Ton-That H, Su K, Schneewind O (2002) An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis. Proc Natl Acad Sci U S A 99(4):2293-2298. doi:10.1073/pnas. 032523999 (Pubitemid 34169054)
95. Hammer ND, Skaar EP (2011) Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu Rev Microbiol. doi:10.1146/annurev-micro-090110-102851
96. Torres VJ, Pishchany G, Humayun M, Schneewind O, Skaar EP (2006) Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol 188(24):8421-8429. doi:10.1128/JB.01335-06 (Pubitemid 44894042)
97. Dryla A, Gelbmann D, von Gabain A, Nagy E (2003) Identification of a novel iron regulated staphylococcal surface protein with haptoglobin-haemoglobin binding activity. Mol Microbiol 49(1):37-53 (Pubitemid 36792002)
98. Muryoi N, Tiedemann MT, Pluym M, Cheung J, Heinrichs DE, Stillman MJ (2008) Demonstration of the iron-regulated surface determinant (Isd) heme transfer pathway in Staphylococcus aureus. J Biol Chem 283(42):28125-28136. doi:10.1074/jbc.M802171200
99. Zhu H, Xie G, Liu M, Olson JS, Fabian M, Dooley DM, Lei B (2008) Pathway for heme uptake from human methemoglobin by the iron-regulated surface determinants system of Staphylococcus aureus. J Biol Chem 283(26):18450-18460. doi:10.1074/jbc.M801466200
100. Liu M, Tanaka WN, Zhu H, Xie G, Dooley DM, Lei B (2008) Direct hemin transfer from IsdA to IsdC in the iron-regulated surface determinant (Isd) heme acquisition system of Staphylococcus aureus. J Biol Chem 283(11):6668-6676. doi:10.1074/jbc.M708372200
101. Mazmanian SK, Skaar EP, Gaspar AH, Humayun M, Gornicki P, Jelenska J, Joachmiak A, Missiakas DM, Schneewind O (2003) Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299(5608):906-909. doi:10.1126/science.1081147 (Pubitemid 36182452)
102. Skaar EP, Gaspar AH, Schneewind O (2004) IsdG and IsdI, heme-degrading enzymes in the cytoplasm of Staphylococcus aureus. J Biol Chem 279(1):436-443. doi:10.1074/jbc.M307952200 (Pubitemid 38044844)
103. Wu R, Skaar EP, Zhang R, Joachimiak G, Gornicki P, Schneewind O, Joachimiak A (2005) Staphylococcus aureus IsdG and IsdI, heme-degrading enzymes with structural similarity to monooxygenases. J Biol Chem 280(4):2840-2846. doi:10.1074/jbc.M409526200 (Pubitemid 40189392)
104. Reniere ML, Ukpabi GN, Harry SR, Stec DF, Krull R, Wright DW, Bachmann BO, Murphy ME, Skaar EP (2010) The IsdG-family of haem oxygenases degrades haem to a novel chromophore. Mol Microbiol 75(6):1529-1538. doi:10.1111/j.1365-2958. 2010.07076.x
105. Reniere ML, Skaar EP (2008) Staphylococcus aureus haem oxygenases are differentially regulated by iron and haem. Mol Microbiol 69(5):1304-1315. doi:10.1111/j.1365-2958.2008.06363.x
106. Torres VJ, Stauff DL, Pishchany G, Bezbradica JS, Gordy LE, Iturregui J, Anderson KL, Dunman PM, Joyce S, Skaar EP (2007) A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe 1(2):109-119. doi:10.1016/j.chom.2007.03.001 (Pubitemid 46554913)
107. Stauff DL, Bagaley D, Torres VJ, Joyce R, Anderson KL, Kuechenmeister L, Dunman PM, Skaar EP (2008) Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response. J Bacteriol 190(10):3588-3596. doi:10.1128/JB.01921-07
108. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O, DeLeo FR (2010) Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 202(7):1050-1058. doi:10.1086/656043
109. Bubeck Wardenburg J, Patel RJ, Schneewind O (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 75(2):1040-1044. doi:10.1128/IAI.01313-06 (Pubitemid 46203470)
110. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13(12):1405-1406. doi:10.1038/nm1207-1405 (Pubitemid 350224232)
111. Ji Y, Marra A, Rosenberg M, Woodnutt G (1999) Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J Bacteriol 181(21):6585-6590 (Pubitemid 29517970)
112. Kernodle DS, Voladri RK, Menzies BE, Hager CC, Edwards KM (1997) Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model. Infect Immun 65(1):179-184 (Pubitemid 27008920)
113. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ (1994) Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun 62(6):2478-2482 (Pubitemid 24157079)
114. Patel AH, Nowlan P, Weavers ED, Foster T (1987) Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 55(12):3103-3110 (Pubitemid 18008284)
115. Ragle BE, Bubeck Wardenburg J (2009) Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect Immun 77(7):2712-2718. doi:10.1128/IAI.00115-09
116. Cheng AG, Kim HK, Burts ML, Krausz T, Schneewind O, Missiakas DM (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 23(10):3393-3404. doi:10.1096/fj.09-135467
117. Kim HK, DeDent A, Cheng AG, McAdow M, Bagnoli F, Missiakas DM, Schneewind O (2010) IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine 28(38):6382-6392. doi:10.1016/j.vaccine.2010.02.097
118. Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE Jr, Fabry ME, Skaar EP (2010) Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe 8(6):544-550. doi:10.1016/j.chom.2010.11.002
119. Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, D'Agostino N, Miorin L, Buccato S, Mariani M, Galli G, Nogarotto R, Nardi Dei V, Vegni F, Fraser C, Mancuso G, Teti G, Madoff LC, Paoletti LC, Rappuoli R, Kasper DL, Telford JL, Grandi G (2005) Identification of a universal group B streptococcus vaccine by multiple genome screen. Science 309(5731):148-150. doi:10.1126/science.1109869 (Pubitemid 40934997)
120. Stranger-Jones YK, Bae T, Schneewind O (2006) Vaccine assembly from surface proteins of Staphylococcus aureus. ProcNatl Acad Sci U S A 103(45):16942-16947. doi:10.1073/pnas.0606863103 (Pubitemid 44737357)
121. Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, Pancari G, Fan H, Isett K, Burgess B, Bryan J, Brownlow M, George H, Meinz M, Liddell ME, Kelly R, Schultz L, Montgomery D, Onishi J, Losada M, Martin M, Ebert T, Tan CY, Schofield TL, Nagy E, Meineke A, Joyce JG, Kurtz MB, Caulfield MJ, Jansen KU, McClements W, Anderson AS (2006) A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 74(4):2215-2223. doi:10.1128/IAI.74.4.2215- 2223.2006
122. Clarke SR, Brummell KJ, Horsburgh MJ, McDowell PW, Mohamad SA, Stapleton MR, Acevedo J, Read RC, Day NP, Peacock SJ, Mond JJ, Kokai-Kun JF, Foster SJ (2006) Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis 193(8):1098-1108. doi:10.1086/501471
123. Ebert T, Smith S, Pancari G, Clark D, Hampton R, Secore S, Towne V, Fan H, Wang XM, Wu X, Ernst R, Harvey BR, Finnefrock AC, Wang F, Tan C, Durr E, Cope L, Anderson A, An Z, McNeely T (2010) A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo. Hum Antibodies 19(4):113-128. doi:10.3233/HAB-2010-0235
124. Harro C, Betts R, Orenstein W, Kwak EJ, Greenberg HE, Onorato MT, Hartzel J, Lipka J, DiNubile MJ, Kartsonis N (2010) Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans. Clin Vaccine Immunol 17(12):1868-1874. doi:10.1128/CVI.00356-10
125. Clarke SR, Wiltshire MD, Foster SJ (2004) IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin. Mol Microbiol 51(5):1509-1519. doi:10.1111/j.1365-2958.2003.03938.x (Pubitemid 38338910)
126. Corrigan RM, Miajlovic H, Foster TJ (2009) Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol 9:22. doi:10.1186/1471-2180-9-22
127. Clarke SR, Andre G, Walsh EJ, Dufrene YF, Foster TJ, Foster SJ (2009) Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect Immun 77(6):2408-2416. doi:10.1128/IAI.01304-08
128. Clarke SR, Mohamed R, Bian L, Routh AF, Kokai-Kun JF, Mond JJ, Tarkowski A, Foster SJ (2007) The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1(3):199-212. doi:10.1016/j.chom.2007.04.005 (Pubitemid 46706363)
129. Palazzolo-Ballance AM, Reniere ML, Braughton KR, Sturdevant DE, Otto M, Kreiswirth BN, Skaar EP, DeLeo FR (2008) Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol 180(1):500-509
130. Clarke SR, Foster SJ (2008) IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin. Infect Immun 76(4):1518-1526. doi:10.1128/IAI.01530-07 (Pubitemid 351561995)
131. Mason WJ, Skaar EP (2009) Assessing the contribution of hemeiron acquisition to Staphylococcus aureus pneumonia using computed tomography. PLoS One 4(8):e6668. doi:10.1371/journal.pone.0006668
132. Attia AS, Benson MA, Stauff DL, Torres VJ, Skaar EP (2010) Membrane damage elicits an immunomodulatory program in Staphylococcus aureus. PLoS Pathog 6(3):e1000802. doi:10.1371/journal.ppat.1000802
133. Aschner JL, Aschner M (2005) Nutritional aspects of manganese homeostasis. Mol Aspects Med 26(4-5):353-362. doi:10.1016/j.mam.2005.07.003 (Pubitemid 41225358)
134. Aschner M, Guilarte TR, Schneider JS, Zheng W (2007) Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 221(2):131-147. doi:10.1016/j.taap.2007.03.001 (Pubitemid 46779052)
135. Friedman BJ, Freeland-Graves JH, Bales CW, Behmardi F, Shorey-Kutschke RL, Willis RA, Crosby JB, Trickett PC, Houston SD (1987) Manganese balance and clinical observations in young men fed a manganese-deficient diet. J Nutr 117(1):133-143 (Pubitemid 17031444)
136. Jakubovics NS, Jenkinson HF (2001) Out of the iron age: new insights into the critical role of manganese homeostasis in bacteria. Microbiology 147(Pt 7):1709-1718 (Pubitemid 32684914)
137. Bartsevich VV, Pakrasi HB (1995) Molecular identification of an ABC transporter complex for manganese: analysis of a cyanobacterial mutant strain impaired in the photosynthetic oxygen evolution process. EMBO J 14(9):1845-1853
138. Que Q, Helmann JD (2000) Manganese homeostasis in Bacillus subtilis is regulated by MntR, a bifunctional regulator related to the diphtheria toxin repressor family of proteins. Mol Microbiol 35(6):1454-1468 (Pubitemid 30175521)
139. Kehres DG, Zaharik ML, Finlay BB, Maguire ME (2000) The NRAMP proteins of Salmonella typhimurium and Escherichia coli are selective manganese transporters involved in the response to reactive oxygen. Mol Microbiol 36(5):1085-1100 (Pubitemid 30330680)
140. Papp-Wallace KM, Maguire ME (2006) Manganese transport and the role of manganese in virulence. Annu Rev Microbiol 60:187-209. doi:10.1146/annurev. micro.60.080805.142149 (Pubitemid 44627946)
141. Fisher S, Buxbaum L, Toth K, Eisenstadt E, Silver S (1973) Regulation of manganese accumulation and exchange in Bacillus subtilis W23. J Bacteriol 113(3):1373-1380
142. Rosch JW, Gao G, Ridout G, Wang YD, Tuomanen EI (2009) Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniae. Mol Microbiol 72(1):12-25. doi:10.1111/j.1365-2958.2009.06638.x
143. Nies DH (2003) Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol Rev 27(2-3):313-339
144. Horsburgh MJ, Wharton SJ, Cox AG, Ingham E, Peacock S, Foster SJ (2002) MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake. Mol Microbiol 44(5):1269-1286 (Pubitemid 34595758)
145. Horsburgh MJ, Clements MO, Crossley H, Ingham E, Foster SJ (2001) PerR controls oxidative stress resistance and iron storage proteins and is required for virulence in Staphylococcus aureus. Infect Immun 69(6):3744-3754. doi:10.1128/IAI.69.6.3744-3754.2001 (Pubitemid 32493293)
146. Kuroda M, Hayashi H, Ohta T (1999) Chromosome-determined zinc-responsible operon czr in Staphylococcus aureus strain 912. Microbiol Immunol 43(2):115-125 (Pubitemid 29091167)
147. Xiong A, Jayaswal RK (1998) Molecular characterization of a chromosomal determinant conferring resistance to zinc and cobalt ions in Staphylococcus aureus. J Bacteriol 180(16):4024-4029 (Pubitemid 28373502)
148. Clements MO, Watson SP, Foster SJ (1999) Characterization of the major superoxide dismutase of Staphylococcus aureus and its role in starvation survival, stress resistance, and pathogenicity. J Bacteriol 181(13):3898-3903 (Pubitemid 29295905)
149. Valderas MW, Hart ME (2001) Identification and characterization of a second superoxide dismutase gene (sodM) from Staphylococcus aureus. J Bacteriol 183(11):3399-3407. doi:10.1128/JB.183.11.3399-3407.2001 (Pubitemid 32448604)
150. Kehl-Fie TE, Chitayat S, Hood MI, Damo S, Restrepo N, Garcia C, Munro KA, Chazin WJ, Skaar EP (2011) Nutrient metalsequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell Host Microbe 10(2):158-164. doi:10.1016/j.chom.2011.07.004
151. Anderson ES, Paulley JT, Gaines JM, Valderas MW, Martin DW, Menscher E, Brown TD, Burns CS, Roop RM 2nd (2009) The manganese transporter MntH is a critical virulence determinant for Brucella abortus 2308 in experimentally infected mice. Infect Immun 77(8):3466-3474. doi:10.1128/IAI.00444-09
152. Boyer E, Bergevin I, Malo D, Gros P, Cellier MF (2002) Acquisition of Mn(II) in addition to Fe(II) is required for full virulence of Salmonella enterica serovar Typhimurium. Infect Immun 70(11):6032-6042 (Pubitemid 35192692)
153. Lim KH, Jones CE, vanden Hoven RN, Edwards JL, Falsetta ML, Apicella MA, Jennings MP, McEwan AG (2008) Metal binding specificity of the MntABC permease of Neisseria gonorrhoeae and its influence on bacterial growth and interaction with cervical epithelial cells. Infect Immun 76(8):3569-3576. doi:10.1128/IAI.01725-07
154. Singh KV, Coque TM, Weinstock GM, Murray BE (1998) In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification. FEMS Immunol Med Microbiol 21(4):323-331 (Pubitemid 28403638)
155. Berry AM, Paton JC (1996) Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect Immun 64(12):5255-5262 (Pubitemid 26403989)
156. Bearden SW, Perry RD (1999) The Yfe system of Yersinia pestis transports iron and manganese and is required for full virulence of plague. Mol Microbiol 32(2):403-414 (Pubitemid 29178705)
157. Gruenheid S, Pinner E, Desjardins M, Gros P (1997) Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med 185(4):717-730 (Pubitemid 27098156)
158. Jabado N, Jankowski A, Dougaparsad S, Picard V, Grinstein S, Gros P (2000) Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med 192(9):1237-1248
159. Forbes JR, Gros P (2003) Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102(5):1884-1892. doi:10.1182/blood-2003-02-0425 (Pubitemid 37022588)
160. Goswami T, Bhattacharjee A, Babal P, Searle S, Moore E, Li M, Blackwell JM (2001) Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J 354(Pt 3):511-519 (Pubitemid 32269714)
161. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D, Skamene E, Olivier M, Jothy S, Gros P (1995) The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 182(3):655-666
162. van Crevel R, Parwati I, Sahiratmadja E, Marzuki S, Ottenhoff TH, Netea MG, van der Ven A, Nelwan RH, van der Meer JW, Alisjahbana B, van de Vosse E (2009) Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. J Infect Dis 200(11):1671-1674. doi:10.1086/648477
163. Jin J, Sun L, Jiao W, Zhao S, Li H, Guan X, Jiao A, Jiang Z, Shen A (2009) SLC11A1 (formerly NRAMP1) gene polymorphisms associated with pediatric tuberculosis in China. Clin Infect Dis 48(6):733-738. doi:10.1086/597034
164. Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS, Kim JW (2005) NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 128(1):94-101. doi:10.1378/chest.128.1.94 (Pubitemid 40994459)
165. Dale I, Fagerhol MK, Naesgaard I (1983) Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 134(1):1-6 (Pubitemid 13051561)
166. Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N (1991) Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem 266(12):7706-7713 (Pubitemid 21906422)
167. Yui S, Nakatani Y, Mikami M (2003) Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 26(6):753-760 (Pubitemid 39655290)
168. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK (1990) Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336(8718):763-765 (Pubitemid 20312185)
169. Sohnle PG, Collins-Lech C, Wiessner JH (1991) Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis 163(1):187-192
170. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303(5663):1532-1535. doi:10.1126/science.1092385 (Pubitemid 38314426)
171. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR, Zychlinsky A (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 5(10):e1000639. doi:10.1371/journal.ppat.1000639
172. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, Shi C, Sukhova GK, Packard RR, Hogg N, Libby P, Simon DI (2009) Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 120(5):427-436. doi:10.1161/CIRCULATIONAHA.108.814582
173. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13(9):1042-1049. doi:10.1038/nm1638 (Pubitemid 47517513)
174. Ehrchen JM, Sunderkotter C, Foell D, Vogl T, Roth J (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86(3):557-566. doi:10.1189/jlb.1008647
175. Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, Zuse A, Hashemi M, Eshraghi M, Schulze-Osthoff K, Klonisch T, Los M (2008) S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta 1783(2):297-311. doi:10.1016/j.bbamcr.2007.10.015
176. Li C, Chen H, Ding F, Zhang Y, Luo A, Wang M, Liu Z (2009) A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway. Biochem J 422(2):363-372. doi:10.1042/BJ20090465
177. Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, Srikrishna G (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181(7):4666-4675
178. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, Roth J, Gabrilovich DI (2008) Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205(10):2235-2249. doi:10.1084/jem.20080132
179. Sohnle PG, Hunter MJ, Hahn B, Chazin WJ (2000) Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J Infect Dis 182(4):1272-1275. doi:10.1086/315810
180. Sohnle PG, Collins-Lech C, Wiessner JH (1991) The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J Infect Dis 164(1):137-142
181. Clohessy PA, Golden BE (1995) Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol 42(5):551-556
182. Lusitani D, Malawista SE, Montgomery RR (2003) Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi. Infect Immun 71(8):4711-4716 (Pubitemid 36919939)
183. Murdoch DA (1998) Gram-positive anaerobic cocci. Clin Microbiol Rev 11(1):81-120
184. Akerstrom B, Bjorck L (2009) Bacterial surface protein L binds and inactivates neutrophil proteins S100A8/A9. J Immunol 183(7):4583-4592. doi:10.4049/jimmunol.0901487
185. DeLeo FR, Diep BA, Otto M (2009) Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am 23(1):17-34. doi:10.1016/j.idc.2008.10.003
186. Pilsczek FH, Salina D, Poon KK, Fahey C, Yipp BG, Sibley CD, Robbins SM, Green FH, Surette MG, Sugai M, Bowden MG, Hussain M, Zhang K, Kubes P (2010) A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol 185(12):7413-7425. doi:10.4049/jimmunol.1000675
187. Prasad AS, Meftah S, Abdallah J, Kaplan J, Brewer GJ, Bach JF, Dardenne M (1988) Serum thymulin in human zinc deficiency. J Clin Invest 82(4):1202-1210. doi:10.1172/JCI113717
188. Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ (1997) Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 272(6 Pt 1):E1002-E1007 (Pubitemid 27293140)
189. Prasad AS (2008) Zinc in human health: effect of zinc on immune cells. Mol Med 14(5-6):353-357. doi:10.2119/2008-00033.Prasad
190. Shankar AH, Prasad AS (1998) Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 68(2 Suppl):447S-463S (Pubitemid 28355620)
191. Sazawal S, Black RE, Bhan MK, Bhandari N, Sinha A, Jalla S (1995) Zinc supplementation in young children with acute diarrhea in India. N Engl J Med 333(13):839-844. doi:10.1056/NEJM199509283331304
192. Sazawal S, Black RE, Jalla S, Mazumdar S, Sinha A, Bhan MK (1998) Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics 102(1 Pt 1):1-5 (Pubitemid 28309237)
193. Lassi ZS, Haider BA, Bhutta ZA (2010) Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev (12):CD005978. doi:10.1002/14651858.CD005978.pub2
194. Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ (2007) Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85(3):837-844 (Pubitemid 46393517)
195. Andreini C, Banci L, Bertini I, Rosato A (2006) Zinc through the three domains of life. J Proteome Res 5(11):3173-3178. doi:10.1021/pr0603699 (Pubitemid 44749234)
196. Patzer SI, Hantke K (1998) The ZnuABC high-affinity zinc uptake system and its regulator Zur in Escherichia coli. Mol Microbiol 28(6):1199-1210 (Pubitemid 28293543)
197. Blencowe DK, Morby AP (2003) Zn(II) metabolism in prokaryotes. FEMS Microbiol Rev 27(2-3):291-311 (Pubitemid 36694660)
198. Shin JH, Jung HJ, An YJ, Cho YB, Cha SS, Roe JH (2011) Graded expression of zinc-responsive genes through two regulatory zinc-binding sites in Zur. Proc Natl Acad Sci U S A 108(12):5045-5050. doi:10.1073/pnas.1017744108
199. Grass G, Wong MD, Rosen BP, Smith RL, Rensing C (2002) ZupT is a Zn(II) uptake system in Escherichia coli. J Bacteriol 184(3):864-866 (Pubitemid 34150239)
200. Rensing C, Mitra B, Rosen BP (1997) The zntA gene of Escherichia coli encodes a Zn(II)-translocating P-type ATPase. Proc Natl Acad Sci U S A 94(26):14326-14331 (Pubitemid 28041372)
201. Nies DH, Silver S (1989) Plasmid-determined inducible efflux is responsible for resistance to cadmium, zinc, and cobalt in Alcaligenes eutrophus. J Bacteriol 171(2):896-900
202. Hassan MT, van der Lelie D, Springael D, Romling U, Ahmed N, Mergeay M (1999) Identification of a gene cluster, czr, involved in cadmium and zinc resistance in Pseudomonas aeruginosa. Gene 238(2):417-425 (Pubitemid 29447034)
203. Singh VK, Xiong A, Usgaard TR, Chakrabarti S, Deora R, Misra TK, Jayaswal RK (1999) ZntR is an autoregulatory protein and negatively regulates the chromosomal zinc resistance operon znt of Staphylococcus aureus. Mol Microbiol 33(1):200-207 (Pubitemid 29304200)
204. Nucifora G, Chu L, Misra TK, Silver S (1989) Cadmium resistance from Staphylococcus aureus plasmid pI258 cadA gene results from a cadmium-efflux ATPase. Proc Natl Acad Sci U S A 86(10):3544-3548 (Pubitemid 19141818)
205. Lindsay JA, Foster SJ (2001) Zur: a Zn(2+)-responsive regulatory element of Staphylococcus aureus. Microbiology 147(Pt 5):1259-1266 (Pubitemid 32454644)
206. Cousins RJ, Leinart AS (1988) Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin 1. FASEB J 2(13):2884-2890
207. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448-454. doi:10.1056/ NEJM199902113400607 (Pubitemid 29084777)
208. Liuzzi JP, Lichten LA, Rivera S, Blanchard RK, Aydemir TB, Knutson MD, Ganz T, Cousins RJ (2005) Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A 102(19):6843-6848. doi:10.1073/pnas.0502257102 (Pubitemid 40675404)
209. Pless DD, Ruthel G, Reinke EK, Ulrich RG, Bavari S (2005) Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell activators. Infect Immun 73(9):5358-5366. doi:10.1128/IAI.73.9.5358-5366.2005 (Pubitemid 41192969)
210. Conrady DG, Brescia CC, Horii K, Weiss AA, Hassett DJ, Herr AB (2008) A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc Natl Acad Sci U S A 105(49):19456-19461. doi:10.1073/pnas.0807717105
211. Sitthisak S, Knutsson L, Webb JW, Jayaswal RK (2007) Molecular characterization of the copper transport system in Staphylococcus aureus. Microbiology 153(Pt 12):4274-4283. doi:10.1099/mic.0.2007/009860-0
212. Grossoehme N, Kehl-Fie TE, Ma Z, Adams KW, Cowart DM, Scott RA, Skaar EP, Giedroc DP (2011) Control of copper resistance and inorganic sulfur metabolism by paralogous regulators in Staphylococcus aureus. J Biol Chem 286(15):13522-13531. doi:10.1074/jbc.M111.220012
213. Liu T, Ramesh A, Ma Z, Ward SK, Zhang L, George GN, Talaat AM, Sacchettini JC, Giedroc DP (2007) CsoR is a novel Mycobacterium tuberculosis copper-sensing transcriptional regulator. Nat Chem Biol 3(1):60-68. doi:10.1038/nchembio844 (Pubitemid 46005700)
214. Banci L, Bertini I, Ciofi-Baffoni S, Del Conte R, Gonnelli L (2003) Understanding copper trafficking in bacteria: interaction between the copper transport protein CopZ and the N-terminal domain of the copper ATPase CopA from Bacillus subtilis. Biochemistry 42(7):1939-1949. doi:10.1021/bi027096p (Pubitemid 36258666)
215. Radford DS, Kihlken MA, Borrelly GP, Harwood CR, Le Brun NE, Cavet JS (2003) CopZ from Bacillus subtilis interacts in vivo with a copper exporting CPx-type ATPase CopA. FEMS Microbiol Lett 220(1):105-112 (Pubitemid 36324328)
216. Shafeeq S, Yesilkaya H, Kloosterman TG, Narayanan G, Andrew PW, Kuipers OP, Morrissey JA (2011) The cop operon is required for copper homeostasis and contributes to virulence in Streptococcus pneumoniae. Mol Microbiol. doi:10.1111/j.1365-2958.2011.07758.x
217. Wolschendorf F, Ackart D, Shrestha TB, Hascall-Dove L, Nolan S, Lamichhane G, Wang Y, Bossmann SH, Basaraba RJ, Niederweis M (2011) Copper resistance is essential for virulence of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 108(4):1621-1626. doi:10.1073/pnas.1009261108
218. Schwan WR, Warrener P, Keunz E, Stover CK, Folger KR (2005) Mutations in the cueA gene encoding a copper homeostasis P-type ATPase reduce the pathogenicity of Pseudomonas aeruginosa in mice. Int J Med Microbiol 295(4):237-242 (Pubitemid 41020797)
219. Prohaska JR, LukasewyczOA (1981) Copper deficiency suppresses the immune response of mice. Science 213(4507):559-561 (Pubitemid 11045322)
220. White C, Lee J, Kambe T, Fritsche K, Petris MJ (2009) A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem 284(49):33949-33956. doi:10.1074/jbc.M109.070201
221. Arredondo M, Nunez MT (2005) Iron and copper metabolism. Mol Aspects Med 26(4-5):313-327. doi:10.1016/j.mam.2005.07.010 (Pubitemid 41225355)
222. Edvinsson M, Frisk P, Molin Y, Hjelm E, Ilback NG (2008) Trace element balance is changed in infected organs during acute Chlamydophila pneumoniae infection in mice. Biometals 21(2):229-237. doi:10.1007/s10534-007-9114-7 (Pubitemid 351421992)
223. Ramadori G, Van Damme J, Rieder H, Buschenfelde KH Meyer zum(1988) Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol 18(8):1259-1264. doi:10.1002/eji. 1830180817
224. Noyce JO, Michels H, Keevil CW (2006) Potential use of copper surfaces to reduce survival of epidemic meticillin-resistant Staphylococcus aureus in the healthcare environment. J Hosp Infect 63(3):289-297. doi:10.1016/j.jhin.2005.12. 008 (Pubitemid 43812185)
225. Shirai T, Tsuchiya H, Shimizu T, Ohtani K, Zen Y, Tomita K (2009) Prevention of pin tract infection with titanium-copper alloys. J Biomed Mater Res B Appl Biomater 91(1):373-380. doi:10.1002/jbm.b.31412
226. Hall TJ, Wren MW, Jeanes A, Gant VA (2009) A comparison of the antibacterial efficacy and cytotoxicity to cultured human skin cells of 7 commercial hand rubs and Xgel, a new copper-based biocidal hand rub. Am J Infect Control 37(4):322-326. doi:10.1016/j.ajic.2008.09.011
227. Gant VA, Wren MW, Rollins MS, Jeanes A, Hickok SS, Hall TJ (2007) Three novel highly charged copper-based biocides: safety and efficacy against healthcare-associated organisms. J Antimicrob Chemother 60(2):294-299. doi:10.1093/jac/dkm201 (Pubitemid 47243877)
228. Baker J, Sitthisak S, Sengupta M, Johnson M, Jayaswal RK, Morrissey JA (2010) Copper stress induces a global stress response in Staphylococcus aureus and represses sae and agr expression and biofilm formation. Appl Environ Microbiol 76(1):150-160. doi:10.1128/AEM.02268-09
229. Seeley EH, Caprioli RM (2011) MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol 29(3):136-143. doi:10.1016/j.tibtech.2010.12.002
230. Sinha TK, Khatib-Shahidi S, Yankeelov TE, Mapara K, Ehtesham M, Cornett DS, Dawant BM, Caprioli RM, Gore JC (2008) Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging. Nat Methods 5(1):57-59. doi:10.1038/nmeth1147
231. Watrous JD, Dorrestein PC (2011) Imaging mass spectrometry in microbiology. Nat Rev Microbiol 9(9):683-694. doi:10.1038/nrmicro2634